These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4840193

  • 1. [Treatment of severe spastic forms of bronchitis with nitrogen mustard].
    Romański B, Montowska L.
    Pol Tyg Lek; 1974 Jun 03; 30(22):931-3. PubMed ID: 4840193
    [No Abstract] [Full Text] [Related]

  • 2. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
    Sánchez Yus E, Vanaclocha Sebastián F.
    Med Clin (Barc); 1980 Sep 25; 75(5):199-202. PubMed ID: 6999251
    [Abstract] [Full Text] [Related]

  • 3. [Mycosis fungoides treated by local administration of a nitrogen mustard preparation, Erasol].
    Grunnet E, Thulin H, Zachariae H.
    Ugeskr Laeger; 1975 Mar 10; 137(11):621-3. PubMed ID: 1145773
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of aniline mustard in patients with multiple myeloma.
    Kyle RA, Costa G, Cooper MR, Ogawa M, Silver RT, Glidewell O, Holland JF.
    Cancer Res; 1973 May 10; 33(5):956-60. PubMed ID: 4703127
    [No Abstract] [Full Text] [Related]

  • 5. Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.
    Prados M, Rodriguez L, Seager M, Silver P, Levin V.
    Cancer Treat Rep; 1987 Nov 10; 71(11):1105-6. PubMed ID: 3119204
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Current tactics in the treatment of chronic lympholeukemia].
    Faĭnshtein FE, Polianskaia AM, Kaloshina GA, Chernova MK, Enikeeva SM.
    Probl Gematol Pereliv Krovi; 1971 Feb 10; 16(2):6-14. PubMed ID: 5573559
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Ceftriaxone in the treatment of exacerbated chronic bronchitis].
    Rampazzo F, Fantoni U.
    G Ital Chemioter; 1985 Feb 10; 32(2):355-8. PubMed ID: 3833578
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
    Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Bandini G, Cavo M, Galieni P.
    Haematologica; 1988 Feb 10; 73(6):503-8. PubMed ID: 3148513
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Nitrogen mustard in the treatment of asthmatic bronchitis].
    Buttò M, Marasco E, Franzolini P, Scaglione V.
    Lotta Tuberc; 1969 Feb 10; 39(3):163-70. PubMed ID: 5265786
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of triethylene-thiophosphoramide on the vascularization of the corneal transplant].
    Zehetbauer G.
    Wien Med Wochenschr; 1968 Feb 17; 118(7):135-7. PubMed ID: 4876222
    [No Abstract] [Full Text] [Related]

  • 20. [Management of the chronic bronchitis syndrome using a new preparation M 811].
    Eiter E.
    Wien Med Wochenschr; 1968 Apr 06; 118(14):303-7. PubMed ID: 5672075
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.